Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.

Clinical therapeutics - 1 Oct 2011

Cho Hyun-Jung, On Young-Keun, Bang Oh Young, Kim Jong-Won, Huh Wooseong, Ko Jae-Wook, Kim June Soo, Lee Soo-Youn

Abstract excerpt

BACKGROUND: The pharmacokinetics and pharmacodynamics of warfarin are affected by polymorphisms in the genes coding for cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1). OBJECTIVE: The objective of this study was to develop a pharmacogenetic dosing algorithm for warfarin in Korean patients with atrial fibrillation and to compare it with the published pharmacogenetic dosing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Atrial Fibrillation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Drug Administration Schedule

Share to Inactivation, Metabolic

Share to International Normalized Ratio

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 21981797
DOI: 10.1016/j.clinthera.2011.09.004

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.PMID 21981797Read ↗

Evaluation of 16 genotype-guided Warfarin Dosing Algorithms in 310 Korean Patients Receiving Warfarin Treatment: Poor Prediction Performance in VKORC1 1173C Carriers.Semantic proximity Read ↗

Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With VKORC1 1173C.Semantic proximity Read ↗

Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients.Semantic proximity Read ↗

Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.Semantic proximity Read ↗

Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.Semantic proximity Read ↗

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm.Semantic proximity Read ↗

Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population.Semantic proximity Read ↗

Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients.Semantic proximity Read ↗

Development and validation wise assessment of genotype guided warfarin dosing algorithm in Indian population.Semantic proximity Read ↗

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.Semantic proximity Read ↗

Accuracy of an internationally validated genetic-guided warfarin dosing algorithm compared to a clinical algorithm in an Arab population.Semantic proximity Read ↗

Pharmacogenetic Warfarin Dosing Algorithms: Validity in Egyptian Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.